Trastuzumab cotreatment improves survival of mice with PC‐3 prostate cancer xenografts treated with the GRPR antagonist 177 Lu‐DOTAGA‐PEG 2 ‐RM26-Reference-Cited by-同舟云学术

Trastuzumab cotreatment improves survival of mice with PC‐3 prostate cancer xenografts treated with the GRPR antagonist 177 Lu‐DOTAGA‐PEG 2 ‐RM26

Published:2019-05-23 Issue:12 Volume:145 Page:3347-3358
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Mitran Bogdan¹,Rinne Sara S.¹,Konijnenberg Mark W.²,Maina Theodosia³,Nock Berthold A.³,Altai Mohamed⁴,Vorobyeva Anzhelika⁴,Larhed Mats¹⁵,Tolmachev Vladimir⁴,Jong Marion²,Rosenström Ulrika¹,Orlova Anna¹⁵^ORCID

Affiliation:

1. Department of Medicinal ChemistryUppsala University Uppsala Sweden

2. Department of Radiology & Nuclear MedicineErasmus MC Rotterdam The Netherlands

3. Molecular RadiopharmacyINRASTES, NCSR “Demokritos” Athens Greece

4. Department of Immunology, Genetics and PathologyUppsala University Uppsala Sweden

5. Science for Life LaboratoryUppsala University Uppsala Sweden

Funder

Cancerfonden

Vetenskapsrådet

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32401

Reference40 articles.

1. Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options

2. Radiopeptides for Imaging and Therapy: A Radiant Future

3. Gastrin‐releasing peptide receptors in the human prostate: relation to neoplastic transformation;Markwalder R;Cancer Res,1999

4. Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer

5. Receptor radionuclide therapy of tumors: a road from basic research to clinical applications;Bodei L;J Nucl Med,2006

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of ABD-Linked RM26 Conjugates for GRPR-Targeted Drug Delivery;ACS Omega;2024-08-15

2. Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management;PET Clinics;2024-07

3. GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics;Pharmaceutics;2024-04-08

4. Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology;EJNMMI Radiopharmacy and Chemistry;2024-02-16

5. Theranostic Radiopeptides in Nuclear Oncology: Design, Preclinical Screening, and Clinical Translation;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024